BERKSHIRE ASSET MANAGEMENT LLC/PA - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 136 filers reported holding IMMUNITYBIO INC in Q2 2022. The put-call ratio across all filers is 1.87 and the average weighting 0.0%.

Quarter-by-quarter ownership
BERKSHIRE ASSET MANAGEMENT LLC/PA ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q1 2022$84,000
-7.7%
15,0000.0%0.01%
-16.7%
Q4 2021$91,000
-53.3%
15,000
-25.0%
0.01%
-53.8%
Q3 2021$195,000
-31.8%
20,0000.0%0.01%
-31.6%
Q2 2021$286,000
-19.7%
20,000
+33.3%
0.02%
-26.9%
Q1 2021$356,00015,0000.03%
Other shareholders
IMMUNITYBIO INC shareholders Q2 2022
NameSharesValueWeighting ↓
ALLEN HOLDING INC /NY 687,571$4,180,0000.56%
HARBOURVEST PARTNERS LLC 335,709$2,041,0000.26%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$586,0000.20%
SHEETS SMITH WEALTH MANAGEMENT 152,276$926,0000.12%
GSA CAPITAL PARTNERS LLP 129,260$786,0000.10%
Clearwater Capital Advisors, LLC 140,551$855,0000.09%
Virtus ETF Advisers LLC 28,969$176,0000.07%
XTX Topco Ltd 19,159$116,0000.07%
LIBERTY ONE INVESTMENT MANAGEMENT, LLC 49,464$301,0000.04%
Vident Investment Advisory, LLC 168,476$1,024,0000.03%
View complete list of IMMUNITYBIO INC shareholders